Roquefort Investments PLC

LSE:ROQ UK Biotechnology
Market Cap
$20.42K
GBX167.82 Million GBX
Market Cap Rank
#49662 Global
#1396 in UK
Share Price
GBX1.03
Change (1 day)
+0.00%
52-Week Range
GBX0.95 - GBX2.65
All Time High
GBX12.50
About

Roquefort Therapeutics plc, a material biotech company, engages in the development of medicines for the treatment of cancer. Its product portfolio consists of five novel patent-protected pre-clinical anti-cancer medicines, which include Midkine antibodies with significance in vivo efficacy and toxicology studies, as well as orphan drug indication; Midkine RNA oligonucleotide therapeutics with nov… Read more

Roquefort Investments PLC (ROQ) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2025: -0.069x

Based on the latest financial reports, Roquefort Investments PLC (ROQ) has a cash flow conversion efficiency ratio of -0.069x as of June 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-329.55K) by net assets (GBX4.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Roquefort Investments PLC - Cash Flow Conversion Efficiency Trend (2021–2024)

This chart illustrates how Roquefort Investments PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Roquefort Investments PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Roquefort Investments PLC ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Roquefort Investments PLC (2021–2024)

The table below shows the annual cash flow conversion efficiency of Roquefort Investments PLC from 2021 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 GBX4.89 Million GBX-783.73K -0.160x +49.14%
2023-12-31 GBX5.50 Million GBX-1.73 Million -0.315x -44.00%
2022-12-31 GBX7.21 Million GBX-1.58 Million -0.219x +65.93%
2021-12-31 GBX4.08 Million GBX-2.62 Million -0.642x --